Abstract:Cancer forms exhibiting poor prognosis have been extensively researched for therapeutic solutions. One of the conventional modes of treatment, chemotherapy shows inadequacy in its methodology due to imminent side-effects and acquired drug-resistance by cancer cells. However, advancements in nanotechnology have opened new frontiers to significantly alleviate collateral damage caused by current treatments via innovative delivery techniques, eliminating pitfalls encountered in conventional treatments. Properties like reduced drug-clearance and increased dose efficacy by the enhanced permeability and retention effect deem nanoparticles suitable for this application. Optimization of size, surface charge and surface modifications have provided nanoparticles with stealth properties capable of evading immune responses, thus deeming them as excellent carriers of chemotherapeutic agents. Biocompatible and biodegradable forms of polymers enhance the bioavailability of chemotherapeutic agents, and permit a sustained and time-dependent release of drugs which is a characteristic of their composition, thereby providing a controlled therapeutic approach. Studies conducted <i>in vitro</i> and animal models have also demonstrated a synergism in cytotoxicity given the mechanism of action of anticancer drugs when administered in combination providing promising results. Combination therapy has also shown implications in overcoming multiple-drug resistance, which can however be subdued by the adaptable nature of tumor microenvironment. Surface modifications with targeting moieties can therefore feasibly increase nanoparticle uptake by specific receptor-ligand interactions, increasing dose efficacy which can seemingly overcome drug-resistance. This article reviews recent trends and investigations in employing polymeric nanoparticles for effectively delivering combination chemotherapy, and modifications in delivery parameters enhancing dose efficacy, thus validating the potential in this approach for anticancer treatment.

Polymer-drug conjugates as nanomedicine: a review

Innovative Design of Targeted Nanoparticles: Polymer–Drug Conjugates for Enhanced Cancer Therapy

Anticancer nanoparticulate polymer‐drug conjugate

Polymer-Drug Conjugates: Novel Carriers for Cancer Chemotherapy

Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy

Polymer Conjugate as the New Promising Drug Delivery System for Combination Therapy against Cancer

Polymer-Drug Conjugate, a Potential Therapeutic to Combat Breast and Lung Cancer

Polymeric Prodrug by Supramolecular Polymerization

Targeting Cancer using Polymeric Nanoparticle mediated Combination Chemotherapy

Rethinking nanoparticulate polymer-drug conjugates for cancer theranostics

Polymer-drug conjugate therapeutics: advances, insights and prospects

Self-assembled polymer nanostructures for delivery of anticancer therapeutics

Advancements in Cancer Therapeutics: Current Paradigms in Applying Biodegradable Polymer Nanoparticles for Enhanced Management

An Overview of Polymeric Nanoparticles-Based Drug Delivery System in Cancer Treatment

Natural Polymeric Nanobiocomposites for Anti-Cancer Drug Delivery Therapeutics: A Recent Update

Polysaccharide-Drug Conjugates: A Tool for Enhanced Cancer Therapy

Biopolymeric nanocarriers in cancer therapy: unleashing the potency of bioactive anticancer compounds for enhancing drug delivery

Polymeric Nanoparticles: Exploring the Current Drug Development and Therapeutic Insight of Breast Cancer Treatment and Recommendations

Amphiphilic Drug Conjugates As Nanomedicines for Combined Cancer Therapy

Polymer-Based Drug Delivery Systems for Cancer Therapeutics

Advanced Targeted Drug Delivery of Bioactive Nanomaterials in the Management of Cancer